SANGAMO THERAPEUTICS, INC. Available-for-sale Securities, Amortized Cost Basis
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Available-for-sale Securities, Amortized Cost Basis of $169.88 million as of 2016-06-30, per its 10-Q filed 2016-08-04.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2016-08-04
- 2016-06-30: Available-for-sale Securities, Amortized Cost Basis $169.88M.
- 2016-03-31: Available-for-sale Securities, Amortized Cost Basis $183.53M.
- 2015-12-31: Available-for-sale Securities, Amortized Cost Basis $205.44M.
- 2015-09-30: Available-for-sale Securities, Amortized Cost Basis $197.74M.
| Period end | Available-for-sale Securities, Amortized Cost Basis |
|---|---|
| 2016-06-30 | $169.88M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $183.53M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $205.44M 10-Q · filed 2016-08-04 |
| 2015-09-30 | $197.74M 10-Q · filed 2015-10-30 |
| 2015-06-30 | $214.64M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $217.53M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $223.40M 10-K · filed 2016-02-18 |
| 2014-09-30 | $227.41M 10-Q · filed 2014-10-28 |
| 2014-06-30 | $229.32M 10-Q · filed 2014-07-29 |
| 2013-12-31 | $128.21M 10-K · filed 2015-02-25 |
| 2013-09-30 | $62.34M 10-Q · filed 2013-11-04 |
| 2013-06-30 | $62.26M 10-Q · filed 2013-08-02 |
| 2013-03-31 | $68.25M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $73.26M 10-K · filed 2014-02-24 |
| 2012-09-30 | $75.67M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $77.27M 10-Q · filed 2012-08-03 |
| 2011-12-31 | $82.61M 10-K · filed 2013-02-26 |